CareDx, Inc. (CDNA)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$50.88+2.05%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · CDNA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | 458.1 | 379.8 | 333.8 | 280.3 | 321.8 | 296.4 | 192.2 | 127.1 | 76.6 | 48.3 | 40.6 | 28.1 | 27.3 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 48.3 | 40.6 | 28.1 | 27.3 |
| Cost of Revenues | — | — | — | — | — | — | — | 45.5 | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | 81.6 | — | — | — | — | — |
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | 79.9 | 71.4 | 72.4 | 82.4 | 90.4 | 76.5 | 48.9 | 30.7 | 14.5 | 12.4 | 12.4 | 9.3 | 3.8 |
| Operating Income | 108.1 | (30.8) | 40.8 | (203.4) | (77.2) | (29.7) | (22.5) | (24.5) | (15.6) | (20.3) | (37.3) | (11.9) | 1.3 |
| Earnings from Continuing Operations | |||||||||||||
| Other Non-Operating Income / Expenses | 7.1 | 9.7 | 12.1 | 13.2 | 1.0 | (2.4) | 2.8 | 0.6 | — | — | — | — | — |
| Asset Writedown | — | 2.3 | — | 0.0 | 0.8 | 2.4 | 0.0 | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 115.2 | (21.1) | 52.9 | (190.1) | (76.2) | (32.1) | (19.8) | (23.9) | (48.2) | (57.3) | (41.4) | (13.7) | (0.7) |
| Income Tax Expense | 4.2 | 0.3 | 0.3 | 0.1 | 0.4 | (1.4) | (1.0) | (2.0) | (1.4) | (1.7) | (1.6) | 0.0 | (1.5) |
| Net Income | |||||||||||||
| Minority Interest | — | — | — | — | — | — | 0.0 | 0.0 | (0.0) | (0.1) | (0.3) | — | — |
| Net Income | 111.0 | (21.4) | 52.5 | (190.3) | (76.6) | (30.7) | (18.7) | (22.0) | (46.8) | (55.5) | (39.5) | (13.7) | 0.8 |
| Per Share | |||||||||||||
| Basic EPS | 2.16 | (0.40) | 1.00 | (3.54) | (1.44) | (0.59) | (0.40) | (0.52) | (1.31) | (2.38) | (2.39) | (1.16) | 0.13 |
| Diluted EPS | 2.08 | (0.40) | 0.93 | (3.54) | (1.44) | (0.59) | (0.40) | (0.52) | (1.31) | (2.38) | (2.39) | (1.16) | 0.10 |
| Revenue per Share | 8.57 | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 51.5 | 53.3 | 52.8 | 53.8 | 53.3 | 52.2 | 46.5 | 42.2 | 35.6 | 23.3 | 16.5 | 11.9 | 5.8 |
| Diluted Weighted Avg Shares | 53.4 | 53.3 | 56.6 | 53.8 | 53.3 | 52.2 | 46.5 | 42.2 | 35.6 | 23.3 | 16.5 | 11.9 | 9.3 |
| Supplemental | |||||||||||||
| EBITDA | — | (15.8) | 55.0 | (189.0) | (65.6) | (20.9) | (15.5) | (19.0) | (11.4) | (16.6) | (34.4) | (11.1) | 1.8 |
| EBIT | 108.1 | (30.8) | 40.8 | (203.4) | (77.2) | (29.7) | (22.5) | (24.5) | (15.6) | (20.3) | (37.3) | (11.9) | 1.3 |
| Effective Tax Rate | 3.6% | — | — | -0.1% | -0.5% | 4.4% | 5.2% | 8.3% | 3.0% | 3.0% | 3.9% | 0.0% | 208.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.